An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid at any EU pharmacy under Directive 2011/24/EU
These are similar to other GLP-1-class medications and tend to be most pronounced during the initial dose titration phase
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights
The most common side effects include nausea (occurring in up to 44% of patients at weight-loss doses), vomiting (up to 25%), diarrhea (up to 30%), abdominal pain, and constipation
Join tens of thousands of members nationwide who are taking charge of their health with Mochi Health
Authors relationships and activities ES is a member of the Editorial Board of Diabetologia but was not involved in any of the decisions regarding review of this manuscript or its acceptance